Do Not Use - ISMP Canada

Do Not Use - ISMP Canada

The abbreviations, symbols, and dose designations found in this table have been reported as being frequently misinterpreted and involved in harmful medication errors.

  Canada, Misp, Do not use ismp canada

Deprescribing: Managing Medications to Reduce …

Deprescribing: Managing Medications to Reduce Polypharmacy Institute for Safe Medication Practices Canada A KEY PARTNER IN REPORT MEDICATION INCIDENTS Online: www.ismp-canada.org/err_index.htm

  Practices, Safe, Institute, Medication, Institute for safe medication practices

Opioid Pain Medicines Information for Patients …

You have been prescribed an opioid pain medicine that is also known as a narcotic. This leaflet reviews some important safety information about opioids.

  Information, Patients, Medicine, Pain, Pain medicines information for patients

Root Cause Analysis (RCA) - ISMP Canada

What is Root Cause Analysis (RCA)? A systematic process of investigating a critical incident or an adverse outcome to determine the multiple, underlying contributing factors.

  Analysis, Causes, Root, Root cause analysis

ISMP Canada Safety Bulletin

Volume 6, Issue 4 ISMP Canada Safety Bulletin July 16, 2006 The following recommendations are directed toward specific groups for the elimination of dangerous abbreviations in all

  Abbreviations, Misp

Opioid Pain Medicines Information for Patients and …

You have been prescribed an opioid pain medicine that is also known as a narcotic. This leaflet reviews some important safety information about opioids.

  Information

Lowering the Risk of Medication Errors: …

9roxph ,vvxh ,603 &dqdgd 6dihw\ %xoohwlq -dqxdu\ ,qvwlwxwh iru 6dih 0hglfdwlrq 3udfwlfhv &dqdgd 3huplvvlrq lv judqwhg wr vxevfulehuv wr xvh pdwhuldo iurp wkh ,603 &dqdgd 6dihw\ %xoohwlq iru

Patient Safety: Preventing Adverse Events OHA Conference

Patient Safety: Preventing Adverse Events OHA Conference Renaissance Toronto Hotel at SkyDome Toronto June 14, 2004 ... Bates DW, et al. Relationship between medication errors and adverse drug events. J. Gen Intern Med 10:199-205, 1995 ... Of adverse events

  Patients, Drug, Safety, Conference, Events, Preventing, Adverse, Patient safety, Adverse event, Adverse drug events, Preventing adverse events oha conference

Clinical Pharmacy and Prevention of Adverse Drug Events

Clinical Pharmacy and Prevention of Adverse Drug Events by William McLean, PharmD, FASHP, FCCP The medical and pharmacy communities, as well as the general public, continue to be bombarded

  Drug, Events, Adverse, Adverse drug events

Liste de médicaments de niveau d’alerte élevé de l’ISMP

substances de contraste radiologique, par voie i.v. eau stérile pour injection, inhalation et irrigation (sauf les flacons verseurs) dans des contenants de 100 ml et plus chlorure de sodium en injection, hypertonique, de concentration supérieure à 0,9 % Institut pour l’utilisation sécuritaire des médicaments (ISMP)

  Contraste, De contraste

(Microbiological risk assessment series no. 10)

-iii - CONTENTS Acknowledgements vii Contributors ix Foreword xi Abbreviations xiii EXECUTIVE SUMMARY xv RECOMMENDATIONS xix 1. INTRODUCTION 1 1.1 Background 1 1.2 Objectives 4 1.3 Scope 5 1.4 Microorganisms other than Enterobacter sakazakii and Salmonella 5 2.

  Abbreviations

Toxicity equivalence factors for marine biotoxins ...

The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and ...

  Designations

National Quality Forum (NQF) Endorsed Set of 30 …

*The National Quality Forum: “Safe Practices for Better Healthcare – 2/2013 Update” Page 1 of 6 National Quality Forum (NQF) Endorsed Set of 34 Safe Practices*

  Quality, National, Forum, National quality forum

GUIDELINES GUIDELINE ON WHEN TO START …

6 Guideline on when to start antiretroviral therapy and on pre exposure prophylaxis for HIV ABBREVIATIONS AND ACRONYMS AIDS …

  Therapy, Start, Abbreviations, When, Antiretroviral, On when to start, On when to start antiretroviral therapy

HIV/AIDS Programme - who.int

important: addendum to 2006 who guidelines on antiretroviral therapy for hiv infection in adults and adolescents new dosage recommendations for stavudine (d4t)